Standout Papers

Efficacy of azacitidine compared with that of conventional ca... 2000 2026 2008 2017 1.7k
  1. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study (2009)
    Pierre Fenaux, Ghulam J. Mufti et al. The Lancet Oncology
  2. Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia (2009)
    Pierre Fenaux, Ghulam J. Mufti et al. Journal of Clinical Oncology
  3. Report of an international working group to standardize response criteria for myelodysplastic syndromes. (2000)
    Bruce D. Cheson, John M. Bennett et al. PubMed

Immediate Impact

2 by Nobel laureates 20 from Science/Nature 102 standout
Sub-graph 1 of 16

Citing Papers

Acute myeloid leukaemia
2023 Standout
TIM-3 restrains anti-tumour immunity by regulating inflammasome activation
2021 StandoutNature
6 intermediate papers

Works of Steven D. Gore being referenced

Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved
2020
A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure
2018
and 4 more

Author Peers

Author Last Decade Papers Cites
Steven D. Gore 6114 2064 3499 217 7.9k
Ulrich Germing 5254 2333 2347 245 6.9k
Aristoteles Giagounidis 8318 3617 3279 253 10.0k
Daniel A. Pollyea 5838 1562 4507 207 8.1k
Christian Récher 4738 1735 4219 288 8.6k
Jeffrey E. Lancet 5139 2029 3465 432 7.6k
Eva Hellström‐Lindberg 8074 3759 3952 184 10.4k
Giuseppe Visani 3895 1982 2145 279 6.5k
Stéphane de Botton 3946 1304 2991 195 6.0k
Gail J. Roboz 4812 1996 3498 313 7.4k
Vinod Pullarkat 3641 1311 1871 225 5.8k

All Works

Loading papers...

Rankless by CCL
2026